Fosun Pharma

Historical price data

Fosun Pharma's mission is to be the global leading integrator of pharmaceutical and healthcare innovation, delivering 'Better Health for Families Worldwide.' The company has achieved significant milestones, including China's first approved CAR-T cell therapy (Yi Kai Da), a leading biosimilar portfolio, and the WHO-recommended antimalarial Artesun®. Its strategy combines independent R&D with aggressive in-licensing and global partnerships to build a diversified portfolio across therapeutics, vaccines, and diagnostics, supported by a vast commercial network through its stake in Sinopharm.

Integrated multi-modal platform focusing on innovative small molecule drugs, antibody drugs (biosimilars & novel mAbs), and cell therapy (CAR-T), while actively exploring RNA, oncolytic viruses, gene therapy, and PROTACs through partnerships.